- Q3 net loss widened to $33.5M or $0.73 per share vs. $20.2M ($0.56 per share) in prior year
- Cash, equivalents and marketable securities total approximately $352M as of Sept 30, 2026
- QUELL-CV trial enrollment completed with topline data expected in Q4 2026
Why is $BIOA moving today? · SEC 8-K archive
$BIOA SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $BIOA: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $BIOA filing catalyst
Why did $BIOA trigger an AI stock catalyst alert?
$BIOA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -0.5/10). Headline: BioAge Labs Reports Q3 Net Loss of $33.5M ($0.73/Share); Pipeline on Track. Key points: - Q3 net loss widened to $33.5M or $0.73 per share vs. $20.2M ($0.56 per share) in prior year - Cash, equivalents and marketable securities total approximately $352M as of Sept 30, 2026 - QUELL-CV trial enrollment completed with topline data expected in Q4 2026
How did $BIOA stock react after the SEC filing?
After the SEC 8-K for $BIOA, observed market reaction: T0 price $5.54. Past moves do not guarantee future results.
Where can I get real-time $BIOA SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $BIOA via Telegram and the VIP Web Terminal from €10/month.